Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesNika BioTechnology Inc

Nika BioTechnology Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.35 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
2500
Market Cap
429.91M

Momentum Score

…

Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.35
Low
0.35
High
52 Week Price Range
0.20
Low
0.77
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.35
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-1.08
ROE
-
Net Debt
-0.00M
ROCE
25.67%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.08M -0.10M -0.06M -3.18M -0.01M
Net income -0.08M -0.10M -0.06M -3.18M -0.01M
Selling general administrative 0.08M 0.10M 0.06M 0.18M 0.01M
Selling and marketing expenses - - - 0.11M 0.23M
Gross profit - - - - 0.09M
Ebit - - -0.13M -3.25M -0.17M
Ebitda -0.08M -0.10M -0.06M -3.18M -0.01M
Depreciation and amortization - - 0.06M 3.18M 0.01M
Operating income -0.08M -0.10M -0.06M -3.18M -0.01M
Other operating expenses 0.08M 0.10M 0.06M 3.18M 0.01M
Interest expense - - - - 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Income tax expense - - -0.06M -3.18M -0.01M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.09M
Total operating expenses 0.08M 0.10M 0.06M 3.18M 0.01M
Total other income expense net - - - 0.00M -0.15M
Net income from continuing ops -0.08M -0.10M -0.06M -3.18M -0.01M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.02M 0.02M 0.02M 0.00M 0.00M
Intangible assets - - - - 0.65M
Other current assets 0.02M 0.02M - - -
Total liab 0.32M 0.24M 0.10M 0.02M 0.02M
Total stockholder equity -0.30M -0.22M -0.08M -0.02M -0.02M
Other current liab 0.32M 0.48M 0.10M 0.02M 0.16M
Common stock 0.10M 0.10M 0.09M 0.09M 0.04M
Capital stock 0.11M 0.10M 0.09M 0.09M 0.04M
Retained earnings -9.00M -8.93M -3.40M -3.34M -0.15M
Good will - - - - 0.65M
Cash 0.00M 0.00M 0.02M 0.00M 0.00M
Total current liabilities 0.32M 0.24M 0.10M 0.02M 0.01M
Current deferred revenue - - - - 0.00M
Net debt -0.00M 0.24M 0.08M 0.02M 0.02M
Short term debt - 0.24M 0.10M 0.02M 0.01M
Short long term debt - - - - 0.01M
Short long term debt total - 0.24M 0.10M 0.02M 0.02M
Other stockholder equity 8.60M 8.60M 3.23M 3.23M 0.09M
Total current assets 0.02M 0.02M 0.02M 0.00M 0.00M
Net receivables - - - - 0.04M
Long term debt - - - - 0.01M
Accounts payable - - - - 0.04M
Accumulated other comprehensive income - - 0.00M - 5.03M
Non currrent assets other - - - - -0.64M
Non current assets total 0.00M 0.00M 0.00M 0.00M 0.65M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M 0.00M 0.00M 0.00M
Total cashflows from investing activities - - - - -0.01M
Net borrowings 0.08M 0.14M 0.08M 0.02M 0.01M
Total cash from financing activities 0.08M 0.14M 0.08M 0.03M 0.01M
Net income -0.08M -0.10M -0.06M -3.18M -0.01M
Change in cash -0.00M -0.02M 0.02M 0.00M -0.00M
Begin period cash flow 0.00M 0.02M 0.00M 0.00M 0.00M
End period cash flow 0.00M 0.00M 0.02M 0.00M 0.00M
Total cash from operating activities -0.08M -0.15M -0.06M -0.03M -0.01M
Issuance of capital stock - - 0.00M 0.01M 0.00M
Other cashflows from investing activities - - - - -0.01M
Other cashflows from financing activities 0.08M 0.14M 0.08M 0.03M -0.01M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital -0.00M -0.02M - - 0.10M
Stock based compensation - - - 3.15M -
Other non cash items -0.00M -0.04M - 3.15M -
Free cash flow -0.08M -0.14M -0.06M -0.03M -0.01M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
NIKA
Nika BioTechnology Inc		 -
-%		 0.35 - - 1000000.00 - 1000000.00
MKKGY
Merck KGaA ADR		 -0.74
2.19%		 33.06 21.25 14.93 3.10 2.14 3.60
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -
-%		 170.05 24.86 15.11 3.13 1.98 3.08
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.34
1.66%		 21.18 - 10.96 0.01 1.20 2.94
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.72 - 10.66 0.01 1.16 2.94

Profile*

Nika BioTechnology Inc

Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

2269 Merrimack Valley Avenue, Henderson, NV, United States, 89044

702 326 3615

https://www.nikapharmaceuticals.com

Name Title Year Born
Mr. Scott Rose CFO & Exec. Director NA
Mr. Alan Wilson Exec. Officer & Director NA
Ms. Patricia Margaret Wilson Corp. Sec. NA
Mr. James W. McLeod P. Geo. Consultant 1943
Mr. Dimitar Slavchev Savov President, CEO, CFO & Director 1958
Mr. Clifford Redekop Secretary & Director 1949

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…